Rheumatology
Showing page 3 of 6 pages of list content
-
A RANDOMIZED CLINICAL TRIAL OF 2-WEEK METHOTREXATE DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS VACCINATED WITH INACTIVATED SARS-COV-2 VACCINE
This article's authors -
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
This article's authors -
Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal – a multicentre, nationwide study
This article's authors -
Gout and coronavirus disease-19 (COVID-19): the risk of diagnosis and death in the UK Biobank
This article's authors -
Inflammation and autoreactivity define a discrete subset of patients with post-acute sequelae of COVID-19, or long-COVID
This article's authors -
Hybrid immunity versus vaccine-induced immunity against SARS CoV2 in Patients with Autoimmune Rheumatic Diseases
This article's authors -
COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study
This article's authors -
The production of anti-PF4 antibodies in anti-phospholipid antibody-positive patients is not affected by COVID-19 vaccination
This article's authors -
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases
This article's authors -
B cell numbers predict humoral and cellular response upon SARS-CoV-2 vaccination among patients treated with rituximab
This article's authors